The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study

被引:9
|
作者
Alrasheedi, Ahmad A. [1 ]
机构
[1] Qassim Univ, Dept Family & Community Med, Buraydah, Saudi Arabia
关键词
median age; vaccine; testing; european union; europe; covid-19; coronavirus; case-fatality; SARS-COV-2;
D O I
10.7759/cureus.33546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The world has been affected differently by the coronavirus disease 2019 (COVID-19), and Europe reaped the largest number of cases and deaths. Moreover, COVID-19 statistics are dynamic. Objectives The current study aimed to use COVID-19 data to examine the COVID-19 prevalence in Europe by the end of November 2022 and compare the findings globally. Methods The primary data on COVID-19 for each European country were obtained from the "Worldometer" website. The data include the cumulative incidence of COVID-19 per country, the cumulative number of deaths, the total number of tests performed, the number of cases per million population, the number of deaths per million, the number of tests per million, and the total population. The case-fatality rate was calculated (number of deaths/number of cases). In addition, the median age and the vaccination coverage rate (people who received two doses) for each European country were extracted from the "United Nations" website and the "Our World in Data" website, respectively. To compare European countries to the globe, COVID-19 data for each continent were obtained. The analysis of variance (ANOVA) test was used to compare variances across the means of the four parts of Europe based on the geographic division. An independent sample t-test was also used to compare the means between the European Union (EU) states and non-EU states. The Spearman correlation coefficient was used to determine the relationship between different variables across Europe. Results As of December 1, 2022, about 648 million COVID-19 cases and 6.6 million deaths have been recorded worldwide. Europe accounted for nearly 36.8% and 29.5% of all cases and deaths, respectively. Based on the number of deaths per million, Europe was the most affected continent after South America. Nearly 6.8 billion tests have been conducted worldwide, 41% done in Europe; 43 European countries have performed tests more than their population. However, COVID-19 statistics were inconsistent across the four parts of Europe. A significant difference was noticed between Eastern Europe and others, especially Northern Europe and Western Europe. By affiliation with the EU, there was no significant difference. For global comparison, the mean deaths per million, the mean cases per million, and the mean tests per population for European countries were higher than those of the world's countries, although they recorded a lower mean case-fatality rate (CFR). Thirteen European countries were among the 15 most affected countries worldwide based on the number of deaths per million, most located in Eastern and Southern Europe. The number of cases and the number of deaths were significantly proportional to the number of tests performed. Conclusions By the end of November 2022, Europe had the most cases of COVID-19, the most deaths, and the most tests performed, even though it accounts for 9.4% of the world's population. However, COVID-19 data were inconsistent across the four parts of Europe, especially between Eastern Europe and others. Given the natural immunity acquired during the three years and the excellent vaccine coverage in Europe, it is essential to reconsider the definition of a suspected case and establish more specific criteria for testing.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The prevalence of anosmia among patients with COVID-19 in Istanbul, Turkey: A cross-sectional study
    Celikoyar, M. Mazhar
    Kavlakoglu, Nail
    Inan, Basak Oguz
    Guden, Ege Can
    Ruzgar, Ummahan Rumeysa
    Aycicek, Ozlem Kurnaloglu
    Donmeze, Tolga
    Aktan, Erkan
    B-ENT, 2021, 17 (01) : 24 - 30
  • [22] Prevalence of Burnout Syndrome in COVID-19 and Non-COVID-19 Units in University Hospital: A Cross-Sectional Study
    Ulbrichtova, Romana
    Svihrova, Viera
    Tatarkova, Maria
    Svihra, Jan, Jr.
    Novak, Martin
    Hudeckova, Henrieta
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [23] Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study
    Nouchi, Agathe
    Chastang, Julie
    Miyara, Makoto
    Lejeune, Julie
    Soares, Andre
    Ibanez, Gladys
    Saadoun, David
    Morelot-Panzini, Capucine
    Similowski, Thomas
    Amoura, Zahir
    Boddaert, Jacques
    Caumes, Eric
    Bleibtreu, Alexandre
    Lorenzo, Alain
    Tubach, Florence
    Pourcher, Valerie
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (04) : 691 - 697
  • [24] Prevalence of Work-Related Anxiety during the COVID-19 Pandemic A Cross-Sectional Study
    Lindqvist, Anna
    Paulsen, Roland
    SOCIOLOGISK FORSKNING, 2024, 61 (01) : 91 - 110
  • [25] Prevalence and Factors Associated With Compliance With COVID-19 Presidential Lockdown Measures: A Cross-Sectional Study
    Olal, Emmanuel
    Mukunya, David
    Oloya, Johnson Nyeko
    Baguma, Steven
    Okot, Christopher
    Alema, Nelson Onira
    Acullu, Denis
    Ochula, Denish Omoya
    Atim, Pamela Okot
    Odong, Patrick Olwedo
    Okot, Godfrey Smart
    Pebolo, Francis Pebalo
    Oyat, Freddy Wathum Drinkwater
    Ikoona, Eric Nzirakaindi
    Aloyo, Judith
    Kitara, David Lagoro
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2023, 60
  • [26] Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study
    Agathe Nouchi
    Julie Chastang
    Makoto Miyara
    Julie Lejeune
    André Soares
    Gladys Ibanez
    David Saadoun
    Capucine Morélot-Panzini
    Thomas Similowski
    Zahir Amoura
    Jacques Boddaert
    Eric Caumes
    Alexandre Bleibtreu
    Alain Lorenzo
    Florence Tubach
    Valérie Pourcher
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 691 - 697
  • [27] Prevalence and correlates of COVID-19 vaccine hesitancy among the elderly in Qatar: A cross-sectional study
    Abdul Karim, Mustafa
    Reagu, Shuja M.
    Ouanes, Sami
    Waheed Khan, Abdul
    Smidi, Wesam S.
    Al-Baz, Nadeen
    Alabdulla, Majid
    MEDICINE, 2022, 101 (26) : E29741
  • [28] Prevalence of psychological disorders in the COVID-19 epidemic in China: A real world cross-sectional study
    Wang, Minghuan
    Zhao, Qian
    Hu, Caihong
    Wang, Yang
    Cao, Jie
    Huang, Shanshan
    Li, Jin
    Huang, Yanzhu
    Liang, Qiming
    Guo, Zhenli
    Wang, Li
    Ma, Li
    Zhang, Sheng
    Wang, Hongmin
    Zhu, Chunli
    Luo, Wenjing
    Guo, Canshou
    Chen, Chunfa
    Chen, Yu
    Xu, Kang
    Yang, Hongxia
    Ye, Lihua
    Wang, Qing
    Zhan, Peiyan
    Li, Gang
    Yang, Mia Jiming
    Fang, Yuxin
    Zhu, Suiqiang
    Yang, Yuan
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 281 : 312 - 320
  • [29] Prevalence and factors associated with belief in COVID-19 vaccine efficacy in Indonesia: A cross-sectional study
    Effendi, Diyan Ermawan
    Laksono, Agung Dwi
    Pranata, Setia
    Nantabah, Zainul Khaqiqi
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (07) : 308 - 313
  • [30] The prevalence of and factors related to reinfection with COVID-19 in Ahvaz, Iran: A comparative cross-sectional study
    Abedi, Parvin
    Afshari, Poorandokht
    Ansari, Somayeh
    Alavi, Seyed Mohammad
    Dashtpayma, Shohreh
    Amiri, Homayon
    HEALTH SCIENCE REPORTS, 2023, 6 (07)